Therapeutic Solutions International increases authorized common stock from 6.5B to 9.0B shares

THERAPEUTIC SOLUTIONS INTERNATIONAL, INC.

Authorized common stock increased from 6.5 billion to 9.0 billion shares (par $0.001) via Certificate of Amendment filed Jan 7, 2025.
Amendment approved by nonunanimous majority written consent of stockholders; Series A Preferred holder has effective voting control.
Series A Preferred (held by Timothy G. Dixon and Thomas E. Ichim) votes 1M + fully diluted common votes, ensuring control.
Preferred stock authorization unchanged at 5 million shares; no change to fiscal year.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

THERAPEUTIC SOLUTIONS INTERNATIONAL, INC.: Increased authorized shares from 6.5 billion to 9 billion common shares, par value unchanged at $0.001, and 5 million preferred shares still authorized (effective 2025-01-07).

Change: charter amendment
Effective: 2025-01-07

Exact text from the filing

On January 07, 2025, we caused to be filed with the Nevada Secretary of State a Certificate of Amendment to Articles of Incorporation to effect an amendment (the “Amendment”) increasing the aggregate number of shares which the corporation shall have authority to issue from 6,500,000,000 to 9,000,000,000 shares of stock having a $.001 par value per share, and 5,000,000 shares of Preferred Stock having a $.001 par value per share.

View on SEC.gov

Browse all governance changes →

Source: SEC EDGAR

accession 0001493152-25-001670

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.